SCHEMBL29445347

SCHEMBL29445347

C=CC(=O)Oc1cccc2c1C(=O)OC2=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 3/20 0.57
▸ THRB P10828 2/20 0.40
▸ THRA P10827 1/20 0.40
▸ TOP1 P11387 1/20 0.36
▸ MAPT P10636 4/20 0.36
▸ HPGD P15428 4/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ PTGES O14684 1/20 0.34
▸ ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL966421 1.00 TYMS (0.57) TYMSTHRBTHRATOP1MAPT
SCHEMBL27947898 0.82 TYMS (0.39) TYMSTOP1MAPTHPGDALDH1A1
SCHEMBL27947897 0.81 TYMS (0.50) TYMSTHRBTHRANPC1RAB9A
SCHEMBL28729483 0.79 TYMS (0.47) TYMSTHRBTHRATOP1MAPT
SCHEMBL2176042 0.79 KDM4E (0.50) TYMSMAPTHPGDALDH1A1MEN1
SCHEMBL28406639 0.79 TYMS (0.47) TYMSTHRBTHRATOP1MAPT
SCHEMBL13899925 0.78 TYMS (0.52) TYMSTHRBTHRAMAPTHPGD
SCHEMBL9320071 0.78 TTR (0.49) TYMSTHRBTHRAMAPTHPGD
SCHEMBL28707279 0.78 TYMS (0.47) TYMSTHRBTHRAMAPTHPGD
SCHEMBL11908091 0.78 ELANE (0.39) TYMSTOP1MAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11279731-B2 Ligand functional substrates 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11279731-B2 Ligand functional substrates PCNA, POLM, POLL TYMS 1374/4885THRB 3995/4885THRA 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback